Clinical Trials in Progress / Breaking Results

Instructions for “Late Breaking” Clinical Trials in Progress

IHPBA World Congress 2018 invites all interested individuals to submit abstracts for “Clinical Trials in Progress”.

Important Dates
Abstract Submission deadline: 15 May 2018
Notification of Acceptance: 8 June 2018

  • ​Have you organised a novel clinical trial pertaining to hepatopancreatobiliary diseases?
  • ​Are you currently accruing patients to an HPB trial?
  • ​Are you looking to connect with other institutions or investigators to broaden the accrual of a clinical trial in progress?
  • Have you early breaking results of a clinical trial?

Following a competitive selection process trials will be presented by their investigators with vibrant discussion and feedback.  This year’s session will highlight ongoing trials in all phases of clinical research. The session will provide a forum for sharing ideas, publicising trials seeking extramural participation and promoting early results or findings.

Trials will be eligible for a brief oral presentation if they meet the following criteria:

  • Trials must be accruing or have patients under study follow-up
  • Trial results may not have been published at the time of presentation
  • ​Trials must be clinically focused and may include therapeutic, palliative, or diagnostic modalities
  • ​Preliminary results, outcomes and endpoints may be presented

A template is provided for you to submit an abstract by the 15 May 2018. Click here to download the template.

The IHPBA World Congress 2018 Scientific Programme Committee look forward to these exciting updates in your ongoing clinical trials.

Abstract Submission Instructions

  • Abstracts shall be submitted electronically on the abstract form template.
  • The abstract must be written in English.
  • Abstracts are limited to 250 words.
  • 1 Table and/or Image may be included in the abstract
  • Tables/Images must be placed at the end of your abstract.
  • Late submissions after 15 May 2018 will not be accepted

​General Information

  • It is the author’s responsibility to submit a correct abstract.
  • The submitting author will receive all correspondence concerning the abstract and is responsible for informing the other co-authors of the status of the abstract.
  • Acknowledgement of abstract submission will be sent to the stated email address. If you do not receive the confirmation within 24 hours of submission, please contact IHPBA 2018 Abstract Department at ihpba2018.scientific@ihpba.org.
  • Notification of acceptance/rejection of the abstracts will be emailed on or after 8 June 2018
  • Full presentation specifications will be made available on the website and forwarded with the abstract acceptance.